PLMR Stock Analysis: Palomar Holdings | NASDAQ
Insurance - Property & Casualty | NASDAQ, USA | Market Cap: 3.700m USD | 12M Return: 25.2% | US69753M1053 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 28.9M
EPS Trend: 99.7%
Qual. Beats: 12
Rev. Trend: 99.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 7.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Palomar Holdings, Inc. (PLMR) is a U.S. specialty insurance company offering property and casualty coverage to both individuals and businesses. Its product portfolio centers on niche perils often avoided by standard insurers, including residential and commercial earthquake, inland marine, Hawaii hurricane, excess national property, residential flood, assumed reinsurance, and crop insurance. The company also engages in fronting arrangements, a structure in which Palomar issues policies on paper while ceding the underlying risk to partner carriers, a model common among managing general agents (MGAs) operating in the specialty market.
Distribution is conducted through retail agents, program administrators, wholesale brokers, and strategic partnerships, allowing Palomar to reach specialized customer segments without building a large direct sales force. The company was incorporated in 2013 under the name GC Palomar Holdings before rebranding, is headquartered in La Jolla, California, and completed its NASDAQ IPO in April 2019. It is classified within the Financials sector under the Property & Casualty Insurance sub-industry.
- Earthquake and catastrophe losses drive underwriting margin volatility
- Crop insurance segment growth offsets property catastrophe exposure
- Specialty premium growth accelerates across inland marine and fronting lines
| Net Income: 203.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -2.82 > 1.0 |
| NWC/Revenue: -121.3% < 20% (prev -13.16%; Δ -108.1% < -1%) |
| CFO/TA 0.10 > 3% & CFO 415.3m > Net Income 203.2m |
| Net Debt (-1.27b) to EBITDA (280.3m): -4.53 < 3 |
| Current Ratio: 0.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.1m) vs 12m ago -1.86% < -2% |
| Gross Margin: 58.10% > 18% (prev 49.60%; Δ 8.50% > 0.5%) |
| Asset Turnover: 32.12% > 50% (prev 23.99%; Δ 8.12% > 0%) |
| Interest Coverage Ratio: 32.60 > 6 (EBIT TTM 271.4m / Interest Expense TTM 8.33m) |
| A: -0.33 (Total Current Assets 1.57b - Total Current Liabilities 2.89b) / Total Assets 3.96b |
| B: 0.11 (Retained Earnings 453.4m / Total Assets 3.96b) |
| C: 0.08 (EBIT TTM 271.4m / Avg Total Assets 3.40b) |
| D: 0.33 (Book Value of Equity 980.9m / Total Liabilities 2.98b) |
| Altman-Z'' = -0.94 = CCC |
| DSRI: 0.44 (Receivables 655.9m/937.3m, Revenue 1.09b/679.7m) |
| GMI: 0.85 (GM 49.60% / 58.10%) |
| AQI: 1.83 (AQ_t 0.60 / AQ_t-1 0.33) |
| SGI: 1.61 (Revenue 1.09b / 679.7m) |
| TATA: -0.05 (NI 203.2m - CFO 415.3m) / TA 3.96b) |
| Beneish M = -2.70 (Cap -4..+1) = A |
As of October 25, 2026, the stock is trading at USD 141.78 with a total of 254,756 shares traded. Over the past week, the price has changed by +1.57%, over one month by +11.45%, over three months by +10.14% and over the past year by +25.15%.
Current recommended Stop Loss: 132.60 (which is 6.5% or 2.3 ATR below the current price).
Palomar Holdings has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy PLMR.
- StrongBuy: 4
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 159.2 | 12.3% |
P/E Trailing = 18.7873
P/S = 3.3899
P/B = 3.4097
Revenue TTM = 1.09b USD
EBIT TTM = 271.4m USD
EBITDA TTM = 280.3m USD
Long Term Debt = 295.8m USD (from longTermDebt, last quarter)
Short Term Debt = 927k USD (from shortTermDebt, last fiscal year)
Debt = 295.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.27b USD (calculated: Debt 295.8m - CCE 1.57b)
Enterprise Value = 2.43b USD (3.70b + Debt 295.8m - CCE 1.57b)
Interest Coverage Ratio = 32.60 (Ebit TTM 271.4m / Interest Expense TTM 8.33m)
EV/FCF = 5.91x (Enterprise Value 2.43b / FCF TTM 410.8m)
FCF Yield = 16.91% (FCF TTM 410.8m / Enterprise Value 2.43b)
FCF Margin = 37.64% (FCF TTM 410.8m / Revenue TTM 1.09b)
Net Margin = 18.61% (Net Income TTM 203.2m / Revenue TTM 1.09b)
Gross Margin = 58.10% ((Revenue TTM 1.09b - Cost of Revenue TTM 457.3m) / Revenue TTM)
Gross Margin QoQ = 45.86% (prev 68.78%)
Tobins Q-Ratio = 0.61 (Enterprise Value 2.43b / Total Assets 3.96b)
Interest Expense / Debt = 2.81% (Interest Expense 8.33m / Debt 295.8m)
Taxrate = 22.77% (59.9m / 263.1m)
NOPAT = 209.6m (EBIT 271.4m * (1 - 22.77%))
Current Ratio = 0.54 (Total Current Assets 1.57b / Total Current Liabilities 2.89b)
Debt / Equity = 0.30 (Debt 295.8m / totalStockholderEquity, last quarter 980.9m)
Debt / EBITDA = -4.53 (Net Debt -1.27b / EBITDA 280.3m)
Debt / FCF = -3.09 (Net Debt -1.27b / FCF TTM 410.8m)
Total Stockholder Equity = 940.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.98% (Net Income 203.2m / Total Assets 3.96b)
RoE = 21.61% (Net Income TTM 203.2m / Total Stockholder Equity 940.2m)
RoCE = 21.96% (EBIT 271.4m / Capital Employed (Equity 940.2m + L.T.Debt 295.8m))
RoIC = 20.52% (NOPAT 209.6m / Invested Capital 1.02b)
WACC = 3.73% (E(3.70b)/V(4.00b) * Re(3.85%) + D(295.8m)/V(4.00b) * Rd(2.81%) * (1-Tc(0.23)))
Discount Rate = 3.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 74.72 | Cagr: 2.72%
[DCF] Terminal Value 76.66% ; FCFF base≈395.9m ; Y1≈430.4m ; Y5≈534.3m
[DCF] Fair Price = 356.5 (EV 8.18b - Net Debt -1.27b = Equity 9.45b / Shares 26.5m; r=8.35% [WACC [floored]]; 5y FCF grow 9.99% → 2.50% )
EPS Correlation: 99.68 | EPS CAGR: 43.73% | SUE: 2.03 | # QB: 12
Revenue Correlation: 99.69 | Revenue CAGR: 52.06% | SUE: 0.20 | # QB: 0
EPS current Quarter (2026-09-30): EPS=2.61 | Chg30d=+0.82% | Revisions=-40% | Analysts=7
EPS current Year (2026-12-31): EPS=10.08 | Chg30d=-0.24% | Revisions=-50% | GrowthEPS=+28.2% | GrowthRev=+47.0%
EPS next Year (2027-12-31): EPS=11.30 | Chg30d=-0.62% | Revisions=-17% | GrowthEPS=+12.1% | GrowthRev=+24.6%
[Analyst] Revisions Ratio: -55% (up=1, down=7)